A novel in situ hydrophobic ion pairing (HIP) formulation strategy for clinical product selection of a nanoparticle drug delivery system-Reference-Cited by-同舟云学术

A novel in situ hydrophobic ion pairing (HIP) formulation strategy for clinical product selection of a nanoparticle drug delivery system

Published:2016-05 Issue: Volume:229 Page:106-119
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Song Young Ho,Shin Eyoung,Wang Hong,Nolan Jim,Low Susan,Parsons Donald,Zale Stephen,Ashton Susan,Ashford Marianne,Ali Mir,Thrasher Daniel,Boylan Nicholas,Troiano Greg

Funder

AstraZeneca

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Targeted Drug Delivery: Concepts and Design;Devarajan,2014

2. Targeted Delivery of Small and Macromolecular Drugs;Mahato,2010

3. Targeted nanoparticle-based drug delivery and diagnosis;Emerich;J. Drug Target.,2007

4. Nanoparticle-based targeted drug delivery;Singh;Exp. Mol. Pathol.,2009

5. Nanoparticle-based biocompatible and targeted drug delivery: characterization and in vitro studies;Yu;Biomacromolecules,2011

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nor-LAAM loaded PLGA microparticles for treating opioid use disorder;Journal of Controlled Release;2024-09

2. Construction of injectable micron-sized polymorphic vesicles for prolonged local anesthesia with weekly sustained release of ropivacaine;International Journal of Pharmaceutics;2024-08

3. In Vitro Release from Polymeric Core/Shell Nanoparticles through the Lens of Multiscale Modeling;Molecular Pharmaceutics;2024-04-30

4. Nor-LAAM loaded PLGA Microparticles for Treating Opioid Use Disorder;2024-04-11

5. Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target;Translational Lung Cancer Research;2024-03